Angel Broking Bullish

Angel Broking is bullish on IPCA Labs and has strongly put a buy call in its research report.

The brokerage firm does see the recent US FDA ban on the Ratlam plant as a setback, but believes the valuations are attractive. The firm has placed a price target of Rs 736 on the stock. IPCA closed at Rs 645 on the National Stock Exchange.

ICICI Direct Suggests Buying

ICICI Direct is bullish on the stock of Mahindra CIE Auto. The brokerage has set a price target of Rs 260 on the stock. ICICI Direct believes that there is a massive turnaround possibilities in the performance.

"We expect utilisation levels to improve leading EBIT margins to rise to 9% and RoCE to expand to ~16% in FY17E," the firm has said.

The shares closed at Rs 198 on the National Stock Exchange.

Firstcall suggests buying Powergrid

Brokerage firm Firstcall has a buy rating on Powergrid. The firm has set a price target of Rs 165 on the stock.

"We expect that the company surplus scenario is likely to continue for the next three years, will keep its growth story in the coming quarters also. We recommend ‘BUY' in this particular scrip with a target price of Rs 165 for Medium to Long term investment", says Firstcall Research Report.

Power Grid closed at Rs 145 on the NSE.

ICICI Direct sees price of Rs 548 on Tata Motors

ICICI Direct has suggesting buying the stock of Tata Motors.

"We value the stock on an SOTP basis, with JLR at 3.5x EV/EBIDTA basis contributing ~Rs 459/share while domestic business contributes Rs 41/share. Inclusive of other subsidiaries and China JV, we arrive at a target price to Rs 548. Buy the stock", says ICICI Direct research report.

Emkay bullish on Blue Star

Brokerage firm Emkay has suggested buying the shares of Blue Star. 

"BLSR's strategy to (a) selectively bid for orders and (b) pursuing profitability over growth has and will keep in good stead. Increase in the market shares in RAC in a competitive environment is quite commendable. We retain positive bias on Blue Star. We maintain BUY rating with a target of Rs 372/Share (@20X FY17E earnings)", says Emkay Global Financial Services research report.